|
2024-04-03 |
2024-04-01 |
S
Sale
|
Serafini Tito
Non-Executive Director
|
20,788
-32.3%
0.07
USD 1,455
|
20,788
-32.3%
|
0.07
|
USD 1,455
|
|
|
2023-10-23 |
2023-10-19 |
S
Sale
|
BAKER BROS. ADVISORS LP
Former 10% Owner
|
251,902
-7.8%
0.40
USD 101,391
|
251,902
-7.8%
|
0.40
|
USD 101,391
|
|
|
2023-10-23 |
2023-10-19 |
S
Sale
|
BAKER BROS. ADVISORS LP
Former 10% Owner
|
22,837
-7.4%
0.40
USD 9,192
|
22,837
-7.4%
|
0.40
|
USD 9,192
|
|
|
2024-04-03 |
2023-09-01 |
S
Sale
|
Serafini Tito
Non-Executive Director
|
8,393
-11.5%
0.37
USD 3,144
|
8,393
-11.5%
|
0.37
|
USD 3,144
|
|
|
2024-04-03 |
2023-09-01 |
S
Sale
|
Courtney Phillips
GENERAL COUNSEL & SECRETARY
Officer
|
7,061
-12.3%
0.37
USD 2,645
|
7,061
-12.3%
|
0.37
|
USD 2,645
|
|
|
2024-04-03 |
2023-09-01 |
S
Sale
|
Orwin John A
PRESIDENT & CEO
Executive Director
|
22,951
-22.8%
0.37
USD 8,597
|
22,951
-22.8%
|
0.37
|
USD 8,597
|
|
|
2023-08-04 |
2023-08-02 |
S
Sale
|
Courtney Phillips
General Counsel & Secretary
Officer
|
4,076
-6.6%
0.95
USD 3,881
|
4,076
-6.6%
|
0.95
|
USD 3,881
|
|
|
2023-08-04 |
2023-08-02 |
S
Sale
|
CROSS HERB
Chief Financial Officer
Officer
|
5,487
-7.0%
0.95
USD 5,225
|
5,487
-7.0%
|
0.95
|
USD 5,225
|
|
|
2023-08-04 |
2023-08-02 |
S
Sale
|
Serafini Tito
Chief Strategy Officer
Executive Director
|
5,487
-7.0%
0.95
USD 5,225
|
5,487
-7.0%
|
0.95
|
USD 5,225
|
|
|
2023-08-04 |
2023-08-02 |
S
Sale
|
Gould Stephen E
Chief Scientific Officer
Officer
|
4,076
-12.5%
0.95
USD 3,881
|
4,076
-12.5%
|
0.95
|
USD 3,881
|
|
|
2022-09-20 |
2022-09-02 |
S
Sale
|
CROSS HERB
Chief Financial Officer
Officer
|
7,646
-18.1%
1.78
USD 13,573
|
7,646
-18.1%
|
1.78
|
USD 13,573
|
|
|
2022-09-20 |
2022-09-02 |
S
Sale
|
Orwin John A
President & CEO
Executive Director
|
20,908
-17.2%
1.78
USD 37,116
|
20,908
-17.2%
|
1.78
|
USD 37,116
|
|
|
2022-09-20 |
2022-09-02 |
S
Sale
|
Courtney Phillips
General Counsel & Secretary
Officer
|
6,432
-18.1%
1.78
USD 11,418
|
6,432
-18.1%
|
1.78
|
USD 11,418
|
|
|
2022-09-20 |
2022-09-02 |
S
Sale
|
Serafini Tito
Chief Strategy Officer
Executive Director
|
7,646
-18.1%
1.78
USD 13,573
|
7,646
-18.1%
|
1.78
|
USD 13,573
|
|
|
2022-03-08 |
2022-03-04 |
PS
Planned sale
|
Serafini Tito
Chief Strategy Officer
Executive Director
|
30,000
-11.0%
5.00
USD 150,000
|
30,000
-11.0%
|
5.00
|
USD 150,000
|
|
|
2021-09-28 |
2021-09-27 |
PS
Planned sale
|
Serafini Tito
Chief Strategy Officer
Executive Director
|
30,000
-9.9%
6.58
USD 197,541
|
30,000
-9.9%
|
6.58
|
USD 197,541
|
|
|
2021-03-19 |
2021-03-17 |
PS
Planned sale
|
Greenberg Norman Michael
Chief Scientific Officer
Officer
|
2,916
-100.0%
16.73
USD 48,785
|
2,916
-100.0%
|
16.73
|
USD 48,785
|
|
|
2021-03-19 |
2021-03-17 |
PS
Planned sale
|
Greenberg Norman Michael
Chief Scientific Officer
Officer
|
2,084
-100.0%
16.73
USD 34,865
|
2,084
-100.0%
|
16.73
|
USD 34,865
|
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Robinson William Hewitt
Non-Executive Director
|
5,000
-1.3%
16.89
USD 84,450
|
5,000
-1.3%
|
16.89
|
USD 84,450
|
|
|
2021-03-15 |
2021-03-11 |
PS
Planned sale
|
Serafini Tito
Chief Strategy Officer
Executive Director
|
1,500
-0.4%
18.84
USD 28,260
|
1,500
-0.4%
|
18.84
|
USD 28,260
|
|
